Literature DB >> 16704037

Mortality in a large tuberculosis treatment trial: modifiable and non-modifiable risk factors.

T R Sterling1, Z Zhao, A Khan, R E Chaisson, N Schluger, B Mangura, M Weiner, A Vernon.   

Abstract

SETTING: North America.
OBJECTIVES: Tuberculosis (TB) patients in North America often have characteristics that may increase overall mortality. Identifying modifiable risk factors would allow for improvements in outcome.
DESIGN: We evaluated mortality in a large TB treatment trial conducted in the United States and Canada. Persons with culture-positive pulmonary TB were enrolled after 2 months of treatment, treated for 4 more months under direct observation, and followed for 2 years (total observation: 28 months). Cause of death was determined by death certificate, autopsy, and/or clinical observation.
RESULTS: Of 1075 participants, 71 (6.6%) died: 15/71 (21.1%) HIV-infected persons, and 56/1004 (5.6%) non-HIV-infected persons (P < 0.001). Only one death was attributed to TB. Cox multivariate regression analysis identified four independent risk factors for death after controlling for age: malignancy (hazard ratio [HR] 5.28, P < 0.0001), HIV (HR 3.89, P < 0.0001), daily alcohol (HR 2.94, P < 0.0001), and being unemployed (HR 1.99, P = 0.01). The risk of death increased with the number of independent risk factors present (P < 0.0001). Extent of disease and treatment failure/relapse were not associated with an increased risk of death.
CONCLUSIONS: Death due to TB was rare. Interventions to treat malignancy, HIV, and alcohol use in TB patients are needed to reduce mortality in this patient population.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16704037

Source DB:  PubMed          Journal:  Int J Tuberc Lung Dis        ISSN: 1027-3719            Impact factor:   2.373


  38 in total

1.  Educational inequalities in tuberculosis mortality in sixteen European populations.

Authors:  J L Álvarez; A E Kunst; M Leinsalu; M Bopp; B H Strand; G Menvielle; O Lundberg; P Martikainen; P Deboosere; R Kalediene; B Artnik; J P Mackenbach; J H Richardus
Journal:  Int J Tuberc Lung Dis       Date:  2011-11       Impact factor: 2.373

2.  Diabetes mellitus and risk of all-cause mortality among patients with tuberculosis in the state of Georgia, 2009-2012.

Authors:  Matthew J Magee; Mary Foote; David M Maggio; Penelope P Howards; K M Venkat Narayan; Henry M Blumberg; Susan M Ray; Russell R Kempker
Journal:  Ann Epidemiol       Date:  2014-02-08       Impact factor: 3.797

3.  HIV-tuberculosis coinfection in Southern California: evaluating disparities in disease burden.

Authors:  Timothy C Rodwell; Richard F W Barnes; Marisa Moore; Steffanie A Strathdee; Annie Raich; Kathleen S Moser; Richard S Garfein
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

4.  Trends in mortality of tuberculosis patients in the United States: the long-term perspective.

Authors:  Richard F W Barnes; Maria Luisa Moore; Richard S Garfein; Stephanie Brodine; Steffanie A Strathdee; Timothy C Rodwell
Journal:  Ann Epidemiol       Date:  2011-08-05       Impact factor: 3.797

5.  Factors associated with mortality in patients with tuberculosis.

Authors:  David J Horne; Rebecca Hubbard; Masahiro Narita; Alexia Exarchos; David R Park; Christopher H Goss
Journal:  BMC Infect Dis       Date:  2010-08-27       Impact factor: 3.090

6.  Alcohol use and abuse among patients with multidrug-resistant tuberculosis in Botswana.

Authors:  N M Zetola; C Modongo; E C Kip; R Gross; G P Bisson; R G Collman
Journal:  Int J Tuberc Lung Dis       Date:  2012-09-07       Impact factor: 2.373

7.  Alcohol use and clinical manifestations of tuberculosis.

Authors:  Christina T Fiske; Carol D Hamilton; Jason E Stout
Journal:  J Infect       Date:  2008-10-09       Impact factor: 6.072

8.  Deaths among tuberculosis cases in Shanghai, China: who is at risk?

Authors:  Xin Shen; Kathryn Deriemer; Zheng'an Yuan; Mei Shen; Zhen Xia; Xiaohong Gui; Lili Wang; Jian Mei
Journal:  BMC Infect Dis       Date:  2009-06-17       Impact factor: 3.090

9.  Factors associated with mortality in HIV-infected and uninfected patients with pulmonary tuberculosis.

Authors:  Ferdinand M Mugusi; Saurabh Mehta; Eduardo Villamor; Willy Urassa; Elmar Saathoff; Ronald J Bosch; Wafaie W Fawzi
Journal:  BMC Public Health       Date:  2009-11-12       Impact factor: 3.295

10.  Clinical deterioration during antituberculosis treatment in Africa: incidence, causes and risk factors.

Authors:  Dominique J Pepper; Suzaan Marais; Robert J Wilkinson; Feriyl Bhaijee; Gary Maartens; Helen McIlleron; Virginia De Azevedo; Helen Cox; Cheryl McDermid; Simiso Sokhela; Janisha Patel; Graeme Meintjes
Journal:  BMC Infect Dis       Date:  2010-03-30       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.